{"rows":[{"id":3820,"title":"MDMA-induced changes in within-network connectivity contradict the specificity of these alterations for the effects of serotonergic hallucinogens","authors":"Felix Müller, Friederike Holze, Patrick C. Dolder, Laura Ley, Patrick Vizeli, Alain Soltermann, Matthias E. Liechti, Stefan Borgwardt","journal":"Neuropsychopharmacology","publication_date":"2020-11-19","publication_year":2020,"doi":"10.1038/s41386-020-00906-2","pubmed_id":"33219313","openalex_id":"https://openalex.org/W3101729008","source_url":"https://doi.org/10.1038/s41386-020-00906-2","substance_tags":"psilocybin","topic_tags":"Brain Imaging,Pharmacology,Receptor Pharmacology,Default Mode Network,Aging,Healthy Volunteers","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-02 20:42:13","last_checked":"2026-07-02 20:42:13","bibtex":null,"source_record_id":"PMID:33219313","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1038/s41386-020-00906-2","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"PMID:33219313","source_url":"https://doi.org/10.1038/s41386-020-00906-2","doi":"10.1038/s41386-020-00906-2","pmid":"33219313","publication_date":"2020-11-19","importer_version":"2.1.3","text_redistributed":false}},{"id":2042,"title":"Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels","authors":"Madsen Martin K., Fisher Patrick M., Burmester Daniel, Dyssegaard Agnete, Stenbæk Dea S., Kristiansen Sara, Johansen Sys S., Lehel Sczabolz, Linnet Kristian, Svarer Claus, Erritzoe David, Ozenne Brice, Knudsen Gitte M.","journal":"Neuropsychopharmacology","publication_date":"2019-06-01","publication_year":2019,"doi":"10.1038/s41386-019-0324-9","pubmed_id":"30685771","openalex_id":"https://openalex.org/W2914255920","source_url":"https://doi.org/10.1038/s41386-019-0324-9","substance_tags":"psilocybin,psilocin","topic_tags":"Receptor Pharmacology","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-07-01 06:52:05","last_checked":"2026-08-09 08:28:50","bibtex":null,"source_record_id":"PMID:30685771","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1038/s41386-019-0324-9","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:30685771","source_url":"https://doi.org/10.1038/s41386-019-0324-9","doi":"10.1038/s41386-019-0324-9","pmid":"30685771","publication_date":"2019-06-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2041,"title":"Correction: Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels","authors":"Madsen Martin K., Fisher Patrick M., Burmester Daniel, Dyssegaard Agnete, Stenbæk Dea S., Kristiansen Sara, Johansen Sys S., Lehel Sczabolz, Linnet Kristian, Svarer Claus, Erritzoe David, Ozenne Brice, Knudsen Gitte M.","journal":"Neuropsychopharmacology","publication_date":"2019-06-01","publication_year":2019,"doi":"10.1038/s41386-019-0360-5","pubmed_id":"30846853","openalex_id":null,"source_url":"https://doi.org/10.1038/s41386-019-0360-5","substance_tags":"psilocybin,psilocin","topic_tags":"Receptor Pharmacology","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-07-01 06:52:05","last_checked":"2026-08-09 08:28:50","bibtex":null,"source_record_id":"PMID:30846853","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1038/s41386-019-0360-5","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:30846853","source_url":"https://doi.org/10.1038/s41386-019-0360-5","doi":"10.1038/s41386-019-0360-5","pmid":"30846853","publication_date":"2019-06-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2031,"title":"Plasma psilocin critically determines behavioral and neurobiological effects of psilocybin","authors":"Madsen Martin K., Knudsen Gitte M.","journal":"Neuropsychopharmacology","publication_date":"2021-01-01","publication_year":2021,"doi":"10.1038/s41386-020-00823-4","pubmed_id":"32843702","openalex_id":"https://openalex.org/W3081047021","source_url":"https://doi.org/10.1038/s41386-020-00823-4","substance_tags":"psilocybin,psilocin","topic_tags":"General","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-07-01 06:52:05","last_checked":"2026-08-09 08:28:50","bibtex":null,"source_record_id":"PMID:32843702","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:32843702","source_url":"https://doi.org/10.1038/s41386-020-00823-4","doi":"10.1038/s41386-020-00823-4","pmid":"32843702","publication_date":"2021-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":8,"title":"Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participants","authors":"Arikci Denis, Borgulya Joran, Straumann Isabelle, Vizeli Patrick, Luethi Dino, Thomann Jan, Rudin Deborah, Vukalovic Ina, Eckert Anne, Liechti Matthias E., Holze Friederike","journal":"Neuropsychopharmacology","publication_date":"2026-07-01","publication_year":2026,"doi":"10.1038/s41386-026-02428-9","pubmed_id":"42049943","openalex_id":"https://openalex.org/W7157683682","source_url":"https://doi.org/10.1038/s41386-026-02428-9","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Pharmacology,Consciousness,Emotional Processing,In Vitro Study,Healthy Volunteers","study_type":"Clinical Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:28:48","bibtex":null,"source_record_id":"PMID:42049943","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1038/s41386-026-02428-9","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42049943","source_url":"https://doi.org/10.1038/s41386-026-02428-9","doi":"10.1038/s41386-026-02428-9","pmid":"42049943","publication_date":"2026-07-01","importer_version":"2.1.3","text_redistributed":false}}],"total":5,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Neuropsychopharmacology","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}